These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 959240)

  • 1. The influence of formulation on the percutaneous absorption of proflavine hemisulphate.
    Selkirk AB; Dolder R
    Pharm Acta Helv; 1976; 51(6):160-3. PubMed ID: 959240
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Mg++ and polyamines on proflavine binding to T2 DNA.
    Riemer SC; Bloomfield VA
    Biopolymers; 1979 Jul; 18(7):1695-708. PubMed ID: 540126
    [No Abstract]   [Full Text] [Related]  

  • 3. Proflavine, proflavine dihydrochloride, proflavine hemisulphate and proflavine monohydrochloride.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1980; 24():195-209. PubMed ID: 7009393
    [No Abstract]   [Full Text] [Related]  

  • 4. Proflavine staining of the skin demonstrated by fluorescent microscopy.
    Bean SF; Felber TD; Knox JM
    Arch Dermatol; 1973 Feb; 107(2):204-5. PubMed ID: 4685576
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of proflavin binding to bacteriophages T2L and T4D.
    McCall PJ; Bloomfield VA
    Biopolymers; 1976 Dec; 15(12NA-NA-770103-770104):2323-36. PubMed ID: 1000044
    [No Abstract]   [Full Text] [Related]  

  • 6. Flow cytometric analysis of proflavine uptake into normal rat hepatocytes and cells arising during AAF-induced hepatocarcinogenesis.
    Austin EB; Holmes CH; Robins RA; Baldwin RW
    Carcinogenesis; 1984 Sep; 5(9):1173-7. PubMed ID: 6467506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic inactivation of verrucae vulgares. I.
    Veien NK; Wettermark G; Genner J; Brodthagen H
    Acta Derm Venereol; 1977; 57(5):441-4. PubMed ID: 73311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence decay and quantum yield characteristics of acridine orange and proflavine bound to DNA.
    Kubota Y; Steiner RF
    Biophys Chem; 1977 Apr; 6(3):279-89. PubMed ID: 880342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of DNA interactions with daunomycin and proflavine in a solution].
    Veselkov AN; Moroshkina EB; Soboleva OI; Frisman EV
    Mol Biol (Mosk); 1984; 18(2):481-7. PubMed ID: 6717424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid binding drugs. Part XIII. Molecular motion in a drug-nucleic acid model system: thermal motion analysis of a proflavine-dinucleoside crystal structure.
    Aggarwal AK; Neidle S
    Nucleic Acids Res; 1985 Aug; 13(15):5671-84. PubMed ID: 4034394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of double-stranded breaks in DNA by binding with an 125i-labelled acridine.
    Martin RF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1977 Nov; 32(5):491-7. PubMed ID: 303635
    [No Abstract]   [Full Text] [Related]  

  • 12. The elusive permeability barriers and binding sites for proflavine in Escherichia coli.
    Gravelle MJ; Mehta BM; Kushner DJ
    Antimicrob Agents Chemother; 1972 Jun; 1(6):470-5. PubMed ID: 4618456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption of proflavine by gram-positive and gram-negative organisms.
    PEACOCKE AR
    Exp Cell Res; 1954 Nov; 7(2):498-504. PubMed ID: 13220593
    [No Abstract]   [Full Text] [Related]  

  • 14. 'Petite' mutagenesis in Saccharomyces cerevisiae by a series of 2,7-di-alkyl-substituted derivatives of proflavine with differing DNA-binding properties.
    Ferguson LR; Denny WA; Feigon J
    Mutat Res; 1988 Sep; 201(1):213-8. PubMed ID: 3047573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of proflavine hemisulphate from proflavine preparations currently in use within the Mersey Regional Health Authority.
    Hunt PB; Ford JL
    J Clin Hosp Pharm; 1983 Dec; 8(4):345-8. PubMed ID: 6662971
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantum chemical calculations on the two-step mechanism of proflavin binding to DNA.
    Pack GR; Hashimoto GM; Loew GH
    Ann N Y Acad Sci; 1981; 367():240-9. PubMed ID: 6942753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular basis for the action of some DNA-binding drugs.
    Neidle S
    Prog Med Chem; 1979; 16():151-221. PubMed ID: 95595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of proflavine on the Feulgen reaction in hepatic cells of the white rat].
    Van amme D; Roels H
    C R Seances Soc Biol Fil; 1974; 168(2-3):352-5. PubMed ID: 4282300
    [No Abstract]   [Full Text] [Related]  

  • 19. The acridine dyes: their purification, physiochemical, and cytochemical properties. II. Purification of acriflavine and proflavine and their cytochemical behaviour regarding machine-oriented evaluation.
    Tiffe HW; Matzke KH; Thiessen G
    Histochemistry; 1977 Jul; 53(1):63-77. PubMed ID: 561770
    [No Abstract]   [Full Text] [Related]  

  • 20. The rate of proflavin passage into single living cells with application to permeability studies.
    ROBBINS E
    J Gen Physiol; 1960 Mar; 43(4):853-66. PubMed ID: 14437748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.